The Incidence of Febrile Neutropenia in the First Course of Adjuvant Chemotherapy with Docetaxel/Cyclophosphamide with or without Pegfilgrastim.

被引：0
|
作者：
Jones, S. [1 ]
Paul, D. [1 ]
Sedlacek, S. [1 ]
Vukelja, S. [1 ]
Wilks, S. T. [1 ]
Stokoe, C. [1 ]
Osborne, C. R. [1 ]
Krekow, L. [1 ]
McIntyre, K. [1 ]
Holmes, F. A. [1 ]
Guerra, L. [1 ]
Zhan, F. [1 ]
Asmar, L. [1 ]
O'Shaughnessy, J. [1 ]
Blum, J. L. [1 ]
机构：
[1] US Oncol, The Woodlands, TX USA
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/0008-5472.SABCS11-P5-18-09
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P5-18-09
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Febrile neutropenia and role of prophylactic granulocyte colony-stimulating factor in docetaxel and cyclophosphamide chemotherapy for breast cancer
    Kimura, Yuri
    Sasada, Shinsuke
    Emi, Akiko
    Masumoto, Norio
    Kadoya, Takayuki
    Okada, Morihito
    SUPPORTIVE CARE IN CANCER, 2021, 29 (07) : 3507 - 3512
  • [32] Optimal primary febrile neutropenia prophylaxis for patients receiving docetaxel–cyclophosphamide chemotherapy for breast cancer: a systematic review
    Ricardo Fernandes
    Sasha Mazzarello
    Carol Stober
    Lisa Vandermeer
    Shaan Dudani
    Mohamed F. K. Ibrahim
    Habeeb Majeed
    Kirstin Perdrizet
    Risa Shorr
    Brian Hutton
    Dean Fergusson
    Mark Clemons
    Breast Cancer Research and Treatment, 2017, 161 : 1 - 10
  • [33] Febrile neutropenia and role of prophylactic granulocyte colony-stimulating factor in docetaxel and cyclophosphamide chemotherapy for breast cancer
    Yuri Kimura
    Shinsuke Sasada
    Akiko Emi
    Norio Masumoto
    Takayuki Kadoya
    Morihito Okada
    Supportive Care in Cancer, 2021, 29 : 3507 - 3512
  • [34] Primary prophylaxis with 3 weekly pegfilgrastim and ciproflaxacin effectively prevent (febrile) neutropenia and infection during neoadjuvant chemotherapy with docetaxel/doxorubicin/cyclophosphamide (TAC) in breast cancer patients.
    von Minckwitz, G
    Blohmer, JU
    Löhr, A
    Raab, G
    Eidtmann, H
    Gerber, B
    Hilfrich, J
    Huober, J
    Costa, SD
    Jackisch, C
    Kaufmann, M
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 731S - 731S
  • [35] Phase III placebo-controlled, double-blind, randomized trial of pegfilgrastim to reduce the risk of febrile neutropenia in breast cancer patients receiving docetaxel/cyclophosphamide chemotherapy
    Kosaka, Yoshimasa
    Rai, Yoshiaki
    Masuda, Norikazu
    Takano, Toshimi
    Saeki, Toshiaki
    Nakamura, Seigo
    Shimazaki, Ryutaro
    Ito, Yoshinori
    Tokuda, Yutaka
    Tamura, Kazuo
    SUPPORTIVE CARE IN CANCER, 2015, 23 (04) : 1137 - 1143
  • [36] PEGFILGRASTIM AS PROPHYLAXIS OF FEBRILE NEUTROPENIA DURING CHEMOTHERAPY OF RELAPSED AND REFRACTORY MULTIPLE MYELOMA
    Cerchione, C.
    Pugliese, N.
    Marano, L.
    Cerciello, G.
    Avilia, S.
    Pane, F.
    Catalano, L.
    HAEMATOLOGICA, 2013, 98 : 424 - 424
  • [37] Pegfilgrastim for the prevention of chemotherapy-induced febrile neutropenia in patients with solid tumors
    Lambertini, Matteo
    Ferreira, Arlindo R.
    Del Mastro, Lucia
    Danesi, Romano
    Pronzato, Paolo
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2015, 15 (12) : 1799 - 1817
  • [38] Clinical Impact of Primary Prophylactic Pegfilgrastim in Breast Cancer Patients Receiving Adjuvant Docetaxel-Doxorubicin-Cyclophosphamide Chemotherapy
    Jeon, Ye Won
    Lim, Seung Taek
    Gwak, HongKi
    Park, Seon Young
    Suh, Young Jin
    JOURNAL OF BREAST CANCER, 2020, 23 (05) : 521 - 532
  • [39] Effect of 3 mg versus 6 mg pegfilgrastim on the prevention of febrile neutropenia in breast cancer patients receiving docetaxel and cyclophosphamide: a retrospective study
    Zhang, Zhisheng
    Li, Huan
    Zhang, Jiacheng
    Ye, Xuan
    Liu, Hongyue
    Zhai, Qing
    Yu, Bo
    Du, Qiong
    ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (05) : 5310 - 5315
  • [40] Incidence of febrile neutropenia and effectiveness of pegfilgrastim prophylaxis in patients with advanced-stage solid tumors receiving chemotherapy.
    Crawford, Jeffrey
    Reiner, Maureen
    Morrow, Phuong Khanh H.
    Lyman, Gary H.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345